ABSI Butterfly Strategy

ABSI (Absci Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

ABSI (Absci Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.70B, a beta of 2.46 versus the broader market, a 52-week range of 2.24-11.36, average daily share volume of 5.8M, a public-listing history dating back to 2021, approximately 156 full-time employees. These structural characteristics shape how ABSI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.46 indicates ABSI has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a butterfly on ABSI?

A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.

Current ABSI snapshot

As of June 30, 2026, spot at $11.50, ATM IV 120.20%, IV rank 51.17%, expected move 34.46%. The butterfly on ABSI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this butterfly structure on ABSI specifically: ABSI IV at 120.20% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 34.46% (roughly $3.96 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABSI expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABSI should anchor to the underlying notional of $11.50 per share and to the trader's directional view on ABSI stock.

ABSI butterfly setup

The ABSI butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABSI near $11.50, the first option leg uses a $11.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABSI chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABSI shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$11.00$1.58
Sell 2Call$11.00$1.58
Buy 1Call$12.00$0.95

ABSI butterfly risk and reward

Net Premium / Debit
+$62.50
Max Profit (per contract)
$62.50
Max Loss (per contract)
-$37.50
Breakeven(s)
$11.63
Risk / Reward Ratio
1.667

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.

ABSI butterfly payoff curve

Modeled P&L at expiration across a range of underlying prices for the butterfly on ABSI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

ABSI butterfly profit and loss curve at expiration with breakevens and current spot markedABSI butterfly payoff at expiration-$20$0$20$40$60$5$10$15$20Underlying Price ($)P&L at Expiration ($)BE $11.63Spot $11.50
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-99.9%+$62.50
$2.55-77.8%+$62.50
$5.09-55.7%+$62.50
$7.63-33.6%+$62.50
$10.18-11.5%+$62.50
$12.72+10.6%-$37.50
$15.26+32.7%-$37.50
$17.80+54.8%-$37.50
$20.34+76.9%-$37.50
$22.88+99.0%-$37.50

When traders use butterfly on ABSI

Butterflies on ABSI are pinning bets - traders use them when they expect ABSI to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.

ABSI thesis for this butterfly

The market-implied 1-standard-deviation range for ABSI extends from approximately $7.54 on the downside to $15.46 on the upside. A ABSI long call butterfly is a pinning play: it pays maximum at the middle strike if ABSI settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current ABSI IV rank near 51.17% is mid-range against its 1-year distribution, so the IV signal is neutral; the butterfly thesis on ABSI should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ABSI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABSI-specific events.

ABSI butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABSI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABSI alongside the broader basket even when ABSI-specific fundamentals are unchanged. Always rebuild the position from current ABSI chain quotes before placing a trade.

Frequently asked questions

What is a butterfly on ABSI?
A butterfly on ABSI is the butterfly strategy applied to ABSI (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With ABSI stock trading near $11.50, the strikes shown on this page are snapped to the nearest listed ABSI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ABSI butterfly max profit and max loss calculated?
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the ABSI butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 120.20%), the computed maximum profit is $62.50 per contract and the computed maximum loss is -$37.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ABSI butterfly?
The breakeven for the ABSI butterfly priced on this page is roughly $11.63 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ABSI market-implied 1-standard-deviation expected move is approximately 34.46%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a butterfly on ABSI?
Butterflies on ABSI are pinning bets - traders use them when they expect ABSI to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
How does current ABSI implied volatility affect this butterfly?
ABSI ATM IV is at 120.20% with IV rank near 51.17%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related ABSI analysis